0001209191-20-063355.txt : 20201214 0001209191-20-063355.hdr.sgml : 20201214 20201214200028 ACCESSION NUMBER: 0001209191-20-063355 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201211 FILED AS OF DATE: 20201214 DATE AS OF CHANGE: 20201214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bratica Joseph CENTRAL INDEX KEY: 0001820070 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 201387841 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: STE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-12-11 1 0000873303 Sarepta Therapeutics, Inc. SRPT 0001820070 Bratica Joseph 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 0 1 0 0 Principal Financial Officer Common Stock 2020-12-11 4 M 0 1115 71.45 A 9255 D Common Stock 2020-12-11 4 S 0 1115 165.00 D 8140 D Stock Option (right to buy) 71.45 2020-12-11 4 M 0 1115 0.00 D 2019-03-05 2028-03-05 Common Stock 1115 12285 D This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. /s/ Joseph Bratica 2020-12-14